Patent applications reinforce Dewpoint s leadership in the discovery of condensate-modifying drugs c-mods to treat diseases of high unmet needNew first-in-class composition of matter targeting TDP- condensates to correct complex ALS-associated neuronal dysfunction BOSTON Jan GLOBE NEWSWIRE -- Dewpoint Therapeutics Inc a biotechnology company that translates the novel science of condensates into breakthrough therapeutics today announced the filing of multiple...
Globe News Wire
SAN DIEGO Jan GLOBE NEWSWIRE -- Shareholder rights law firm Johnson Fistel LLP announces that a class action lawsuit has commenced on behalf of investors of Maison Solutions Inc NASDAQ MSS The class action is on behalf of shareholders who purchased or otherwise acquired Maison Solutions in or traceable to Maison Solutions October initial public offering the IPO The class...
Capital return to be conducted through synthetic share repurchase Return of up to million maximum approved by shareholders in designed to enable efficient return of cash to shareholders and enhance EPS Implementation planned to be completed in late January Venlo the Netherlands Jan GLOBE NEWSWIRE -- QIAGEN N V NYSE QGEN Frankfurt Prime Standard QIA today announced a plan to...
CARLSBAD Calif Jan GLOBE NEWSWIRE -- Exagen Inc Nasdaq XGN a leading provider of autoimmune testing solutions today announces select preliminary unaudited financial results for the full year ended December and reaffirms its full-year financial guidance Select Preliminary Unaudited Financial Results Record AVISE CTD testing volume of approximately units delivered during the year ended December Cash balance of million as...